Managing Type 2 Diabetes: The Impact of Secure Patient-Provider Messaging
Secure messaging presents an opportunity for patients and healthcare providers to collaborate on self-management issues like glycemic control, diet, and exercise.
Diabetes Technology
DIABETES TECHNOLOGY
Featured Article
Latest News
Key Recommendations for Diabetes Technology: ADA 2019 Standards of Care
A review published in the Annals of Internal Medicine outlines the 2019 ADA guidelines for self-monitoring of blood glucose and the use of continuous glucose monitors and automated insulin delivery systems.
How Crowd-Sourced “Looping” Technology Is Changing Care for Type 1 Diabetes
Years before the first closed-loop insulin delivery system was approved, patients with diabetes had already been implementing the technology into their own care.
Smartphone Apps for T2D Self-Management Lack Decision Support, Patient Education
Few smartphone apps for self-management of type 2 diabetes provide sufficient real-time action prompts or education on blood glucose monitoring.
G6 CGM System Offers Improved Accuracy in Youth and Adults With Diabetes
Investigators evaluate the performance of the G6 factory-calibrated continuous glucose monitoring system over 10 days.
FDA Approves FreeStyle Libre 14 Day Flash Glucose Monitoring System
The new Flash Glucose Monitoring System enables patients to wear the sensor for up to 14 days compared with the existing FreeStyle Libre System that was approved for 10-day wear.
Improved Glycemic Control With Closed-Loop Insulin Delivery System
Researchers conducted a randomized, open-label trial to assess the effect of an automated closed-loop insulin delivery system on glycemic control in hospitalized patients.
Technosphere Inhaled Insulin Improves Glycemic Control in Type 1 Diabetes
Patients were randomly assigned to receive insulin aspart or Technosphere inhaled insulin.
Safety and Performance of Omnipod HCL for Children With Type 1 Diabetes
In children with type 1 diabetes, the Omnipod hybrid closed-loop personal model system was safe and performed well.
ITCA 650 Shows Efficacy in Reducing Weight, HbA1c in Type 2 Diabetes
The ITCA 650, a small titanium osmotic mini-pump, provides a subcutaneous infusion of exenatide over 3 or 6 months.
Continuous Glucose Monitoring Controls Hypoglycemia Better Than Glucometer
Participants completed surveys for fear of hypoglycemia, hypoglycemia unawareness, and problem areas in diabetes questionnaire.
Implantable Continuous Glucose Monitoring Device Safe, Effective for Adolescents
The safety assessment included incidence of insertion or procedure-related removal and device-related serious adverse events through 180 after insertion.
Want to read more?
Please login or register first to view this content.
